Disease management
Also: Virtual ketamine therapy company Nue Life Health brings in $23 million in Series A and debt financing, and Source Health launches out of stealth with a $3 million seed.
Dr. Spencer Dorn, gastroenterologist, professor and vice chair of medicine for care innovation at the University of North Carolina, writes on the potential for innovation to change gastroenterology care.
Also: Pear Therapeutics receives FDA SteP designation for its product candidate focused on acute and chronic pain, and Carbon Health launches its diabetes management program.
The digital platform enables clinicians to adjust their patient's devices remotely and in real-time.
Patients work with dietitians to build meal plans and have ingredients delivered to their homes.
The BUZUD smartwatches can also measure blood oxygen levels, blood pressure, and heart rate.
The algorithm analyses EHR data and learns treatment patterns of type 2 diabetes patients.
Hinge Health's study found participants in its digital musculoskeletal care program reported higher levels of pain improvement compared with the group without intervention.
Also: Diabetes care company Podimetrics raised $45 million, and employer-focused hybrid startup Radish Health brought in $4 million in seed funding.
The tech giant also provided an update on its artificial intelligence research and announced the expansion of YouTube's tools to mitigate the spread of health misinformation.